Congenital syphilis: A continuing but neglected problem

Seminars in Fetal and Neonatal Medicine

Volumn 12, Issue 3, 2007, Pages 198-206

  Walker, Godfrey J A ^a   Walker, Damian G ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Congenital syphilis; Cost effectiveness; Diagnosis; Epidemiology; Management

Indexed keywords

BENZATHINE PENICILLIN; ERYTHROMYCIN; PENICILLIN G; PROCAINE PENICILLIN;

AFRICA; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL SYPHILIS; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DOSAGE SCHEDULE COMPARISON; EUROPE; FOLLOW UP; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION RISK; LABORATORY TEST; PATHOGENESIS; PRENATAL CARE; PRENATAL SCREENING; PREVALENCE; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE DRUG DOSE; TREPONEMA PALLIDUM;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; MASS SCREENING; PENICILLINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SYPHILIS, CONGENITAL;

EID: 34247628503     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.01.019     Document Type: Review

References (99)

1. Berman S.M. Maternal syphilis: pathophysiology and treatment. Bull World Health Organ 82 (2004) 433-438
2. Woods C.R. Syphilis in children: congenital and acquired. Semin Pediatr Infect Dis 16 4 (2005) 245-257
3. Desperthes B.D., Meheus A., O'Reilly K., and Broutet N. Maternal and congenital syphilis programmes: case studies in Bolivia, Kenya and South Africa. Bull World Health Organ 82 (2004) 410-416
4. Walker D.G., and Walker G.J.A. Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infect Dis 2 (2002) 432-436
5. Hook III E.W., and Peeling R.W. Syphilis control-a continuing challenge. N Engl J Med 353 (2004) 122-124
6. Walker D.G., and Walker G.J.A. Prevention of congenital syphilis-time for action. Bull World Health Organ 82 (2004) 401
7. World Health Organization. Global prevalence and incidence of curable STIs (2001), World Health Organization, Geneva WHO/CDS/CDR/EDC/2001.10
8. St. Louis M.E., and Wasserheit J.N. Elimination of syphilis in the United States. Science 281 (1998) 353-354
9. Centers for Disease Control and Prevention, Division of STD Prevention. The national plan to eliminate syphilis from the United States (1999), National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta
10. Centers for Disease Control and Prevention. Together we can. The national plan to eliminate syphilis from the United States (May 2006), US Department of Health and Human Services, Atlanta, GA
11. Centers for Disease Control and Prevention, Division of STD Prevention. Sexually transmitted diseases surveillance 2004 supplement. Syphilis surveillance report (2005), National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta
12. Fenton K.A. A multilevel approach to understanding the resurgence and evolution of infectious syphilis in Western Europe. Eurosurveillance 9 10-11 (2004) 3-4
13. Simms I., and Ward H. Congenital syphilis in the United Kingdom. Are we prepared?. Sex Transm Infect 82 1 (2006) 1
14. Yakubovsky A., Sokolovsky E., Miller W.C., Sparling P.F., Ryder R.W., and Hoffman I.F. Syphilis management in St. Petersburg, Russia: 1995-2001. Sex Transm Dis 33 4 (2006) 244-249
15. Health Protection Agency. All new diagnoses made at GUM clinics: 1996-2005 United Kingdom and country specific tables (2006), HPA, London
16. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2004 (September 2005), U.S. Department of Health and Human Services, Atlanta, GA
17. Tikhonova L., Salakhov E., Southwick K., Shakarishvili A., Ryan C., and Hillis S. Congenital Syphilis Investigation Team. Congenital syphilis in the Russian Federation: magnitude, determinants, and consequences. Sex Transm Infect 79 2 (2003) 106-110
18. Salakhov E., Tikhonova L., Southwick K., Shakarishvili A., Ryan C., and Hillis S. Congenital Syphilis Investigation Team. Congenital syphilis in Russia: the value of counting epidemiologic cases and clinical cases. Sex Transm Dis 31 2 (2004) 127-132
19. Begum A., Nilufar S., Akther K., Rahman A., Khatoon F., and Rahman M. Prevalence of selected reproductive tract infections among pregnant women attending an urban childcare unit in Dhaka, Bangladesh. J Health Population Nutr 21 2 (2003) 112-116
20. Garg S., Sharma N., Bhalla P., et al. Reproductive morbidity in an Indian urban slum: need for health action. Sex Transm Infect 78 1 (2002) 68-69
21. Rowley J., and Berkley S. Sexually transmitted diseases. In: Murray C.J.L., and Lopez A.D. (Eds). Health dimensions of sex and reproduction: the global burden of sexually transmitted diseases, HIV, maternal conditions, perinatal disorders, and congenital anomalies (1998), WHO, Harvard School of Public Health, and World Bank, Geneva 19-110
22. Douglas K.-G., Behets F., Brathwaite A., Williams Y., Chatoor R., and Figueroa P. Syphilis control among pregnant women: an evaluation at delivery in Kingston, Jamaica. Venereology-The Interdisciplinary Int J Sex Health 1 2 (1998) 15-18
23. Ministry of Health (MOH) [Uganda] and ORC Macro. Uganda HIV/AIDS Sero-behavioural Survey 2004-2005 (2006), Ministry of Health and ORC Macro, Calverton, Maryland, USA
24. Institut National de la Statistique (INSTAT) [Madagascar] and ORC Macro. Enquête Démographique et de Santé, Madagascar 2003-2004: Rapport de synthèse (2005), INSTAT and ORC, Calverton, MD, USA
25. Ghana AIDS Commission. 2004 HIV sentinel survey report. Accra: Ghana AIDS Commission; 2005.
26. Central Statistical Office [Zambia], Central Board of Health [Zambia], and ORC. Zambia demographic and health survey 2001-2002 (2003), Central Statistical Office, Central Board of Health, and ORC, Calverton, Maryland, USA
27. Mbopi Keou F.-X., Mbu R., Mauclere P., et al. Antenatal HIV prevalence in Yaounde, Cameroon. Int J STD AIDS 9 (1998) 400-402
28. Qolohle D.C., Hoosen A.A., Moodley J., Smith A.N., and Mlisana K.P. Serological screening for sexually transmitted infections in pregnancy: is there any value in re-screening for HIV and syphilis at the time of delivery?. Genitourinary Med 71 (1995) 65-67
29. Goh B.T. Syphilis in adults. Sex Transm Infect 81 (2005) 448-452
30. Karumudi U.R., and Augenbraun M. Syphilis and HIV: a dangerous duo. Expert Rev Anti Infect Ther 3 (2005) 825-831
31. Mullick S., Broutet N., Htun Y., Temmerman M., and Ndowa F. Controlling congenital syphilis in the era of HIV/AIDS. Bull World Health Organ 82 (2004) 431-432
32. Gray R.H., Li X., Kigozi G., et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 366 9492 (2005) 1182-1188
33. Peeling R.W., Mabey D., Fitzgerald D.W., and Watson-Jones D. Avoiding HIV and dying of syphilis. Lancet 364 9445 (2004) 1561-1563
34. Finelli L., Berman S.M., Koumans E.H., and Levine W.C. Congenital syphilis. Bull World Health Organ 76 Suppl. 2 (1998) 126-128
35. Schmid G. Economic and programmatic aspects of congenital syphilis prevention. Bull World Health Organ 82 (2004) 402-409
36. Genc M., and Ledger W.J. Syphilis in pregnancy. Sex Transm Infect 76 2 (2000) 73-79
37. Gichangi P., Renterghem L.V., Karanja J., Bwayo J., Kiragu D., and Temmerman M. Congenital syphilis in a Nairobi maternity hospital. East Afr Med J 81 11 (2004) 589-593
38. McFarlin B.L., Bottoms S.F., Dock B.S., and Isada N.B. Epidemic syphilis: maternal factors associated with congenital infection. Am J Onstet Gynecol 170 2 (1994) 535-540
39. Bateman D.A., Phibbs C.S., Joyce T., and Heragarty M.C. The hospital costs of congenital syphilis. J Pediatr 10 (1997) 752-758
40. Saloojee H., Velaphi S., Goga Y., Afadapa N., Steen R., and Lincetto O. The prevention and management of congenital syphilis: an overview and recommendations. Bull World Health Organ 82 (2004) 424-430
41. Fraser C.M., Norris S.J., Weinstock G.M., et al. Completed genome sequence of Treponema pallidum, the syphilis spirochete. Science 281 (1998) 375-388
42. Gust D.A., Levine W.C., St Louis M.E., Braxton J., and Berman S.M. Mortality associated with congenital syphilis in the United States, 1992-1998. Pediatrics 109 5 (2002) E79-E90
43. Goldenberg R.L., and Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 189 3 (2003) 861-873
44. Watson-Jones D., Changalucha J., Gumodoka B., et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 186 7 (2002) 940-947
45. Sheffield J.S., Sanchez P.J., Morris G., et al. Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 186 3 (2002) 569-573
46. Goldenberg R.L., Culhane J.F., and Johnson D.C. Maternal infection and adverse fetal and neonatal outcomes. Clin Perinatol 32 3 (2005) 523-559
47. Jenson H.B. Congenital syphilis. Semin Pediatr Infect Dis 10 3 (1999) 183-194
48. Fiumara N.J., and Lessell S. The stigmata of late congenital syphilis: an analysis of 100 patients. Sex Transm Dis 10 3 (1983) 126-129
49. Peeling R.W., and Ye H. Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview. Bull World Health Organ 82 6 (2004) 439-446
50. Egglestone S.I., and Turner A.J.L. Serological diagnosis of syphilis. Communicable Dis Public Health 3 3 (2000) 158-162
51. Cross A., Luck S., Patey R., Sharland M., Rice P., and Chakraborty R. Syphilis in London circa 2004: new challenges from an old disease. Arch Dis Childhood 90 (2005) 1045-1046
52. Yetman R.J., Risser W.L., Barth B.A., Risser J.M., and Hwang L.Y. Problems in physician's classification and reporting of congenital syphilis. Int J STD AIDS 9 12 (1998) 765-768
53. Rawstron S.A., Mehta S., and Bromberg K. Evaluation of a Treponema pallidum-specific IgM enzyme immunoassay and Treponema pallidum western blot antibody detection in the diagnosis of maternal and congenital syphilis. Sex Transm Dis 31 2 (2004) 123-126
54. World Health Organization/Special Programme for Research and Training in Tropical Diseases. Laboratory-based evaluation of rapid syphilis diagnostics: results from 8 SDI sites, TDR/SDI/DE/03.1 (2003), The Sexually Transmitted Diseases Diagnostics Initiative (SDI), Geneva UNDP/World Bank/WHO
55. Montoya P.J., Lukehart S.A., Brentlinger P.E., et al. Comparison of the diagnostic accuracy of a rapid immunochromatographic test and the rapid plasma reagin test for antenatal syphilis screening in Mozambique. Bull World Health Organ 84 2 (2006) 97-104
56. British Association for Sexual Health and HIV (BASHH). Clinical effectiveness group (Association for Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). UK national guidelines on the management of early syphilis (2002), BSSHH, London
57. Valderrama J., Urquia Bautista A., Orlich G., et al. Maternal and congenital syphilis: case definitions. Epidemiol Bull 26 1 (2005) 12-15
58. Ingraham N.R. The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Derm Venereol Suppl (Stokh) 31 Suppl. 24 (1951) 60-88
59. Holmes K.K. Azithromycin versus penicillin for early syphilis [The editorialist replies]. N Engl J Med 354 (2006) 205
60. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR 55 No. RR-11 (2006) 1-100
61. Wendel Jr. G.D., Sheffield J.S., Hollier L.M., Hill J.B., Ramsey P.S., and Sanchez P.J. Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis 35 Suppl. 2 (2002) S200-S209
62. Walker G.J.A. Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev 3 (2006) 10.1002/14651858.CD001143 Art. No.: CD001143
63. World Health Organization. Guidelines for the management of sexually transmitted infections (2003), WHO, Geneva
64. Rolfs R.T., Joesoef M.R., Hendershot E.F., et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 337 5 (1997) 307-314
65. Watson-Jones D., Gumodoka B., Weiss H., et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis 186 7 (2002) 948-957
66. Myer L., Karim S.S.A., Lombard C., and Wilkinson D. Treatment of maternal syphilis in rural South Africa: effect of multiple doses of benzathine penicillin on pregnancy loss. Trop Med Int Health 9 11 (2004) 1216-1221
67. Radcliffe M., Meyer M., Roditi D., and Malan A. Single-dose benzathine penicillin in infants at risk of congenital syphilis-results of a randomised study. S Afr Med J 87 (1997) 62-65
68. Paryani S.G., Vaughn A.J., Crosby M., and Lawrence S. Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. J Pediatr 125 3 (1994) 471-475
69. Blank S., McDonnell D.D., Rubin S.R., et al. New approaches to syphilis control. Finding opportunities for syphilis treatment and congenital syphilis prevention in a women's correctional setting. Sex Transm Dis 24 (1997) 218-226
70. Lago E.G., Rodrigues L.C., Fiori R.M., and Stein A.T. Congenital syphilis: identification of two distinct profiles of maternal characteristics associated with risk. Sex Transm Dis 31 1 (2004) 33-37
71. Maupin Jr. R., Lyman R., Fatsis J., et al. Characteristics of women who deliver with no prenatal care. J Mat-Fetal Neonatal Med 16 1 (2004) 45-50
72. WHO and UNICEF. Antenatal care in developing countries: promises, achievements and missed opportunities: an analysis of trends, levels and differentials, 1990-2001 (2003), WHO, Geneva
73. Gloyd S., Chai S., and Mercer M.A. Antenatal syphilis in sub-Saharan Africa: missed opportunities for mortality reduction. Health Policy Plan 16 1 (2001) 29-34
74. Terris-Prestholt F., Watson-Jones D., Mugeye K., et al. Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect 79 5 (2003) 375-381
75. Watson-Jones D., Oliff M., Terris-Prestholt F., et al. Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania. Trop Med Int Health 10 9 (2005) 934-943
76. Hawkes S., Miller S., Reichenbach L., Nayyar A., and Buse K. Antenatal syphilis control: people, programmes, policies and politics. Bull World Health Organ 82 (2004) 417-423
77. Hira S.K., Bhat G.J., Chikamata D.M., et al. Syphilis intervention in pregnancy: Zambian demonstration project. Genitourinary Med 66 (1990) 159-164
78. Temmerman M., Gichangi P., Fonck K., et al. Effect of a syphilis control programme on pregnancy outcome in Nairobi, Kenya. Sex Transm Infect 76 (2000) 117-121
79. Fitzgerald D.W., Behets F., Preval J., Schulwolf L., Bommi V., and Chaillet P. Decreased congenital syphilis incidence in Haiti's rural Artibonite region following decentralized prenatal screening. Am J Public Health 93 (2003) 444-446
80. Jenniskens F., Obwaka E., Kirisuah S., et al. Syphilis control in pregnancy: decentralization of screening facilities to primary care level, a demonstration project in Nairobi, Kenya. Int J Obstet Gynecol 48 Suppl. (1995) S121-S128
81. Fonck K., Claeys P., Bashir F., Bwayo J., Fransen L., and Temmerman M. Syphilis control during pregnancy: effectiveness and sustainability of a decentralized program. Am J Public Health 91 (2001) 705-707
82. Stay-Pedersen B. Economic evaluation of maternal screening to prevent congenital syphilis. Sex Transm Dis 10 4 (1983) 167-172
83. Kiss H., Widhalm A., Geusau A., and Husslein P. Universal antenatal screening for syphilis: is it still justified economically? A 10-year retrospective analysis. Eur J Obstet Gynecol Reprod Biol 112 1 (2004) 24-28
84. Connor N., Roberts J., and Nicoll A. Strategic options for antenatal screening for syphilis in the United Kingdom. J Med Screen 7 (2000) 7-13
85. Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development (2001), Center for International Development at Harvard University, Boston
86. Lumbiganon P., Piaggio G., Villar J., et al. The epidemiology of syphilis in pregnancy. Int J STD AIDS 13 7 (2002) 486-494
87. Wawer M.J., Sewankambo N.K., Serwadda D., et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 353 9152 (1999) 525-535
88. Walker S.L., and Hay R.J. Yaws: a review of the last 50 years. Int J Dermatol 39 (2000) 258-260
89. Rekart M.L., Patrick D.M., Chakraborty B., et al. Targeted mass treatment for syphilis with oral azithromycin. Lancet 361 9354 (2003) 313-314
90. Pourbohloul B., Rekart M.L., and Brunham R.C. Impact of mass treatment on syphilis transmission: a mathematical modeling approach. Sex Transm Dis 30 4 (2003) 297-305
91. Kiddugavu M.G., Kiwanuka N., Wawer M.J., et al. Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis 32 1 (2005) 1-6
92. Riedner G., Rusizoka M., Todd J., et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 353 (2005) 1236-1244
93. Riedner G., Grosskurth H., and Hayes R. Azithromycin versus penicillin for early syphilis. N Engl J Med 354 (2006) 204-205
94. Ballard R.C., Berman S.M., and Fenton K.A. Azithromycin versus penicillin for early syphilis. N Engl J Med 354 2 (2006) 203-205
95. Norris S.J., and Weinstock G.M. The genome sequence of Treponema pallidum, the syphilis spirochete: will clinicians benefit?. Curr Opin Infect Dis 13 (2000) 29-36
96. Cullen P.A., and Cameron C.E. Progress towards an effective syphilis vaccine: the past, present and future. Expert Rev Vaccines 5 1 (2006) 67-80
97. World Health Organization. Global strategy for the prevention and control of sexually transmitted infections 2006-2015 (2006), WHO, Department of Reproductive Health and Research (RHR), Geneva
98. Walker D.G., and Walker G.J.A. Syphilis: a forgotten priority. PLoS Med 3 4 (2006) 559-560
99. Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Sachs S.E., and Sachs J.D. Syphilis: a forgotten priority [Authors' reply]. PLoS Med 3 4 (2006) e207